Effects of unsaturated side-chain analogs of tetrahydrocannabinol on cytochromes P450

被引:4
作者
Bornheim, LM
机构
[1] Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Ctr Liver, San Francisco, CA 94143 USA
关键词
cytochrome P450; P450; 3A; P4502C; cannabinoids; mechanism-based inactivation; tetrahydrocannabinol;
D O I
10.1016/S0006-2952(00)00431-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The ability of unsaturated side-chain analogs of Δ8- tetrahydrocannabinol (THC) to selectively inactivate mouse hepatic cytochromes P450 3A11 and 2C29 was examined. THC side-chain analogs were preincubated with mouse hepatic microsomes and NADPH for various times before dilution and determination of Δ9-THC metabolism specific for P450s 3A11 and 2C29. THC-enyl analogs had little or no effect on P450 3A11 but inactivated P450 2C29 in a time-dependent manner, with approximately 50% inactivation observed after a 30-min preincubation. THC-ynyl analogs were less selective in their P450 inactivation but appeared to be more effective than their corresponding enyl analogs. THC-ynyl analogs inactivated P450s 3A11 and 2C29 in a time-dependent manner and could inactive 40-80% of their activities after a 30-min preincubation. The THC-ynyl analogs were nearly as effective as cannabidiol, a well-characterized inactivator of these mouse P450s. Despite their ability to inactivate P450 in vitro, neither the THC-enyl nor the THC-ynyl analogs were very effective after in vivo administration. Unsaturated side-chain THC analogs may be useful in the development of specific P450 inactivators. (C) 2000 Elsevier Science Inc.
引用
收藏
页码:955 / 961
页数:7
相关论文
共 35 条
[11]  
de Montellano P.R. O., 1995, Cytochrome P450, P305
[12]  
DEMONTELLANO PRO, 1986, CYTOCHROME P450 STRU, P273
[13]   An investigation into the structural determinants of cannabinoid receptor ligand efficacy [J].
Griffin, G ;
Wray, EJ ;
Rorrer, WK ;
Crocker, PJ ;
Ryan, WJ ;
Saha, B ;
Razdan, RK ;
Martin, BR ;
Abood, ME .
BRITISH JOURNAL OF PHARMACOLOGY, 1999, 126 (07) :1575-1584
[15]  
HARVEY DJ, 1984, REV BIOCHEM TOXICOL, V6, P221
[16]  
Helvig C, 1997, J BIOL CHEM, V272, P414
[17]   17-imidazolyl, pyrazolyl, and isoxazolyl androstene derivatives. Novel steroidal inhibitors of human cytochrome C-17,C-20-lyase (P450(17 alpha)) [J].
Ling, YZ ;
Li, JS ;
Liu, Y ;
Kato, K ;
Klus, GT ;
Brodie, A .
JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (20) :3297-3304
[18]   THE MOLECULAR-BASIS OF CANNABINOID ACTIVITY [J].
MAKRIYANNIS, A ;
RAPAKA, RS .
LIFE SCIENCES, 1990, 47 (24) :2173-2184
[19]   Interaction of sulfaphenazole derivatives with human liver cytochromes P450 2C: Molecular origin of the specific inhibitory effects of sulfaphenazole on CYP 2C9 and consequences for the substrate binding site topology of CYP 2C9 [J].
Mancy, A ;
Dijols, S ;
Poli, S ;
Guengerich, FP ;
Mansuy, D .
BIOCHEMISTRY, 1996, 35 (50) :16205-16212
[20]  
Martin B. R., 1995, CANNABINOID RECEPTOR, P35